NCT03964649View on ClinicalTrials.gov

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

CompletedOBSERVATIONAL
Enrollment

7,308

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions
Arthritis, Rheumatoid
Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03964649 - Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics | Biotech Hunter | Biotech Hunter